Intravenous tenecteplase (TNKase) before endovascular thrombectomy improved outcomes for acute ischemic stroke patients who presented within 4.5 hours after onset in a randomized trial from China.

Furthermore, the levels of native prothrombin antigen during warfarin therapy more closely reflect antithrombotic activity than the PT. 76 These considerations support administering a maintenance dose ...